N66D (p.Asn66Asp) variant of APOA5 (Apolipoprotein A-V)

N66D (p.Asn66Asp) in APOA5 (Apolipoprotein A-V) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data and structural context.

N66D (p.Asn66Asp) variant details